Philip Katz

Philip Katz is a partner in the Life Sciences Regulatory practice at Paul Hastings and is based in the firm’s Washington, D.C. office. He counsels pharmaceutical and biotechnology clients on FDA regulatory matters across the product life cycle. Having led the Band 1-ranked Pharmaceuticals and Biotechnology Regulatory practice at his previous firm, Phil brings deep regulatory knowledge and understanding of agency processes that enable him to advise clients of all sizes on their most business-critical regulatory matters. His clients range from startups developing their first product to large public companies with extensive product portfolios.